NEWTON, Mass., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today announced that Acer’s management team will present and host one-on-one investor meetings at the upcoming H.C. Wainwright Global Investment Conference September 13-15, 2021.

See more here:
Acer Therapeutics to Participate in H.C. Wainwright 23rd Annual Global Investment Conference

Dr. Ziats Joins Clinical Team Involved in Launch and Management of Clinical Studies Across Multiple Indications Dr. Ziats Joins Clinical Team Involved in Launch and Management of Clinical Studies Across Multiple Indications

Read the original post:
XBiotech Announces Addition of Dr. Mark Ziats, M.D. Ph.D. as Medical Director

MORRISVILLE, N.C., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer Alistair Macdonald and Chief Financial Officer Jason Meggs are scheduled to present at the 2021 Baird Global Healthcare Conference on September 15, 2021, at 1:25 p.m. ET.

More:
Syneos Health to Present at the 2021 Baird Global Healthcare Conference

SAN DIEGO, Aug. 30, 2021 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological, COVID-19 and dry eye disease diagnostics, announced today that the Company’s manufacturing partner Empowered Diagnostics has filed an amended emergency use authorization (EUA) with the Food and Drug Administration (FDA) for ImmunoPass™, the Company’s rapid test that detects COVID-19 neutralizing antibodies at point-of-care locations.

Here is the original post:
AXIM® Biotechnologies’ Manufacturing Partner Empowered Diagnostics Files Amended Emergency Use Authorization with FDA for its Rapid COVID-19...

Geographic Expansion into Europe via the Netherlands Geographic Expansion into Europe via the Netherlands

Read the original post:
22nd Century Group Enters Global Specialty Hops Market

Daix (France), August 30, 2021 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS) and other diseases with significant unmet medical need, today announced that the Company’s leadership will participate in four upcoming investor conferences in September 2021.

Continue reading here:
Inventiva announces participation at several investor conferences in September 2021  

Excerpt from:
Galapagos announces planned retirement of CEO

ERYTECH to Participate in the Citi 16th Annual BioPharma Conference

See more here:
ERYTECH to Participate in the Citi 16th Annual BioPharma Conference

BOSTON and LAUSANNE, Switzerland, Aug. 30, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), today announced the company will be participating in the Morgan Stanley 19th Annual Global Healthcare Conference.

Visit link:
SOPHiA GENETICS to Present at the Morgan Stanley 19th Annual Global Healthcare Conference

Kim Popovits to serve as interim CEO Kim Popovits to serve as interim CEO

See the original post here:
Talis Biomedical Announces CEO Transition